JS BIOFUTURE INVEST ApS: Financial statements 2016
CVR: 31080983
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
JS BIOFUTURE INVEST ApS (CVR 31080983) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -4,375 and a net result of DKK -19,733 compared with DKK 5,179 the year before. Equity in the 2016 report amounted to DKK 23,718. The solvency ratio was 28.5%.
- Gross Profit
- DKK -4,375
- Profit/Loss
- DKK -19,733
- Equity
- DKK 23,718
- Total Assets
- DKK 83,161
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -4 t. | -20 t. | 24 t. | - |
| 2015 | - | -9 t. | 5 t. | 43 t. | - |
| 2014 | - | -8 t. | -555 | 38 t. | - |
| 2013 | - | -12 t. | -8 t. | 39 t. | - |
| 2012 | - | - | - | - | - |
Official annual report
Find more companies like JS BIOFUTURE INVEST ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
JS BIOFUTURE INVEST ApS has published its annual report for 2015. Gross profit came to DKK -8,875, and the net result was DKK 5,179.
About JS BIOFUTURE INVEST ApS
JS BIOFUTURE INVEST ApS is a Danish company of the type Anpartsselskab based in Kgs.Lyngby, founded in 2007. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named ApS KBUS 17 NR. 6222. The management consists of Jørgen Schøller. The company is owned by Jørgen Schøller and Anna Carina Wiborg Simonsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -18,598 and a net result of DKK 1,492,381 compared with DKK -8,609 the year before. Equity in the 2025 report amounted to DKK 1,706,887.